Scrutiny of High Drug Costs Require Specialty Pharmacy Strategy Shift

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs with Specialty Pharmacy Times.

How will specialty pharmacies need to change strategies as scrutiny of the high cost of drugs increases?

“There is an underlying current of what a specialty pharmacy is in Congress and in the Senate,” says Suzette. “The unfortunate thing is is that most people don’t know what a specialty pharmacy is until they need one.”

“I think it’s not the specialty pharmacies that are scrutinized in the drug cost,” says Suzette. “I think the burden has to go back to the manufacturer and how they are basing those costs for those products.”

2018-02-21T06:56:08+00:00